P D F - S E A R C H

Found 1 thsd. answers for 'Ecallantide'.

Overview of ecallantide in the treatment of
Introduction to ecallantide Ecallantide is a potent and specific plasma kallikrein inhibitor that blocks generation of bradykinin. Pharmacodynamics Ecallantide delays thrombin generation in vitro [25].

https://www.openaccessjournals.com/articles/overview-of-ecallantide-in-the-treatment-of-hereditary-angioedema-types-i-and-ii.pdf

Indications and usage
KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. 2 dosage and administration. 2.1 Recommended Dosing.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125277s071lbl.pdf

Reactions
KALBITOR () (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. 2 dosage and administration. 2.1 Recommended Dosing.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125277lbl.pdf

Indications and usage
KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older. 2 dosage and administration. 2.1 Recommended Dosing.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125277s070lbl.pdf

Ecallantide
Ecallantide. Brand Names: US. Warning. Ecallantide. This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side...

https://www.mskcc.org/pdf/cancer-care/patient-education/ecallantide

Ecallantide
Ecallantide. Brand Names: US. Warning. Ecallantide. This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side...

https://www.mskcc.org/pdf/cancer-care/patient-education/ecallantide-01

Kalbitor (ecallantide)
Requests for Kalbitor (ecallantide) may be approved for individuals who meet the following criteria: I. Individual is 12 years of age or older; AND II. Individual is using Kalbitor for the treatment of acute...

https://mediproviders.anthem.com/Clinical%20Pharmacy%20Policies/PHARM_ALL_Kalbitor.pdf

Clinical Policy: Ecallantide (Kalbitor)
Description Ecallantide (Kalbitor®) is a plasma kallikrein inhibitor. FDA Approved Indication(s) Kalbitor is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age...

https://www.buckeyehealthplan.com/content/dam/centene/policies/pharmacy-policies/CP.PHAR.177%20Ecallantide.pdf

KALBITOR- ecallantide injection, s olution
ecallantide. 10 mg/mL Injection For Subcutaneous Use Only Single Use; Discard Unused Portion KALBITOR. ecallantide injection, solution. Product Information. Prod uct T yp e Route of Ad minis...

https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f56aec67-c662-477c-b866-bfc23e8809cf&type=pdf&name=f56aec67-c662-477c-b866-bfc23e8809cf

Kalbitor® (ecallantide)
KALBITOR® (ecallantide) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without approval. ©2018, Magellan Rx Management.

https://specialtydrug.magellanprovider.com/media/83064/kalbitor.pdf